The New England Journal of Medicine

OCTOBER 29, 2024

The past two decades have witnessed a renaissance in the evaluation and treatment of patients with valvular heart disease, catalyzed by advances in surgical innovation, transcatheter techniques, and multimodality cardiac imaging.

Aortic valve 40

Aortic valve Tricuspid TAVR Aortic 40

Heart BMJ

MARCH 22, 2024

Objectives This study aimed to evaluate the prognostic value of coronary microvascular dysfunction (CMD) at long term after transcatheter aortic valve implantation (TAVI) and to explore its relationship with extravalvular cardiac damage (EVCD).

Aortic valve 40

Aortic valve Aortic Tricuspid Heart Failure 40

DAIC

APRIL 30, 2024

Tricuspid Valve Repair Existing literature on national surgical outcomes of isolated tricuspid valve repair or replacement is based on data from over a decade ago and may not reflect current practice results. Analysis of 13,587 patients undergoing isolated tricuspid valve surgery from 2017 to 2023 revealed a 5.5%

TAVR 111

TAVR Aortic valve Tricuspid Coronary Artery Bypass Graft 111

DAIC

AUGUST 27, 2024

We know that structural heart disease and heart failure are the leading causes of hospitalization and morbidity in the U.S. This milestone makes AISAP the first company in the world to secure FDA clearance in the CADx pathway for the comprehensive diagnosis of structural heart diseases using POCUS.

Ultrasound 98

Ultrasound Tricuspid Bicuspid/Mitral Aortic 98

DAIC

AUGUST 29, 2024

Echocardiograms using the robotic arm resulted in the same diagnosis as conventional in-person echocardiography in 98% of cases (papillary muscle level obstruction was missed in one case).

Echocardiogram 52

Echocardiogram Bicuspid/Mitral Aortic valve Outpatient 52

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Introduction Bicuspid aortic valve (BAV) is the most common congenital heart disease with an increased risk of infective endocarditis (IE). The aim of this study was to compare patients with tricuspid aortic valve (TAV) IE and BAV-IE in terms of characteristics, management and prognosis.

Aortic valve 69

Aortic valve Bicuspid/Mitral Aortic Congenital Heart Disease 69

DAIC

APRIL 2, 2024

Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve, for which more than 1.6 are affected by tricuspid regurgitation, 1 which can severely impact quality of life. Abbott has announced U.S million people in the U.S. are estimated to be affected.

Tricuspid 105

Tricuspid Heart Valves Quality of Life Open-Heart Surgery 105